From November 1, Specialists and Consultant Physicians will be able to request two new items relating to MRI the evaluation and diagnosis of breast cancer. This is good news for patients and will assist in the treatment of breast cancer, leading to improved health outcomes for women.
63531 – Biopsy has not been possible
MRI of both breasts where the patient has a breast lesion, the results of conventional imaging examinations are inconclusive for the presence of breast cancer.
63533 – The results of breast MRI may alter treatment planning
MRI of both breasts where the patient has been diagnosed with breast cancer, discrepancy exists between clinical assessment and conventional imaging assessment.
Why are these changes being made?
The Government is listing these services as an interim measure for four years, to allow time for research to be undertaken through the Medical Research Future Fund (MRFF) on the benefits and effectiveness of these services and further consideration by the independent expert committee, the Medical Services Advisory Committee (MSAC).
Further details about MSAC applications can be found under MSAC Applications on the MSAC website.
How will these changes affect patients?
These item numbers are in addition to the existing breast MRI items, the changes will provide greater access for diagnosis for patients with possible breast cancer, and assist in treatment and surgical planning in patients with invasive breast cancer, leading to improved health outcomes.